XML 43 R27.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
12 Months Ended
Jun. 30, 2025
Class of Warrant or Right [Line Items]  
SCHEDULE OF FAIR VALUE ASSUMPTIONS OF STOCK OPTIONS

The Company uses the Black-Scholes valuation model to calculate the fair value of warrants. Weighted average annualized percentages and expected term inputs used in Black-Scholes valuations during the periods are listed below:

 

   Year ended June 30, 
   2025(1)   2024 
Expected volatility       -    80.06%
Risk free interest rate   -    4.86 
Dividend yield   -     
Expected term (years)        6.00 

 

(1)No stock options were granted during the year ended June 30, 2025.
SCHEDULE OF STOCK OPTIONS ACTIVITY

Activity in stock options during the year ended June 30, 2025 and related balances outstanding as of that date are reflected below:

 

   Number
of Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
(# years)
   Aggregate
intrinsic
Value
   Weighted
Average
Grant
Date Fair
Value
 
Outstanding at June 30, 2024   1,605,060   $4.85                     
Granted                     - 
Exercised                -      
Forfeited and cancelled   (808,400)   5.60                
Outstanding at June 30, 2025   796,660    4.10    7.10    -      
Exercisable at June 30, 2025   385,189    4.71    6.08    -      

 

Activity in stock options during the year ended June 30, 2024 and related balances outstanding as of that date are reflected below:

 

   Number
of Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
(# years)
   Aggregate
intrinsic
Value
   Weighted
Average
Grant
Date Fair
Value
 
Outstanding at June 30, 2023   973,400   $6.44             
Granted   1,034,204    3.45             $2.24 
Exercised   (100,104)   3.40        $97,593      
Forfeited and cancelled   (302,440)   5.66                
Outstanding at June 30, 2024   1,605,060    4.85    7.96           
Exercisable at June 30, 2024   426,363    8.72    4.92           
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

Activity in RSUs during the year ended June 30, 2025 and related balances outstanding as of that date are reflected below: 

 

   Number
of Shares
   Weighted
Average Grant
Date Fair
Value
   Weighted
Average
Remaining
Contract Term
(# years)
 
Outstanding at June 30, 2024   114,666   $5.56      
Granted   200,000    1.60      
Vested and settled   (102,896)   5.28      
Forfeited and cancelled   (11,770)   8.00      
Outstanding at June 30, 2025   200,000    1.60    0.91 

 

 

Activity in RSUs during the year ended June 30, 2024 and related balances outstanding as of that date are reflected below:

 

   Number
of Shares
   Weighted
Average Grant
Date Fair
Value
   Weighted
Average
Remaining
Contract Term
(# years)
 
Outstanding at June 30, 2023   193,749   $6.09      
Granted   68,228    4.25      
Vested and settled   (136,956)   5.55      
Forfeited and cancelled   (10,355)   6.91      
Outstanding at June 30, 2024   114,666    5.56    0.61 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES

The following table summarizes stock-based compensation expense for employee and non-employee stock option and RSU grants and ESPP participation:

 

       
   Year ended June 30, 
   2025   2024 
Research and development  $127,000   $236,000 
Selling and administrative   852,000    1,335,000 
Total stock-based compensation expense  $979,000   $1,571,000 
Warrant [Member]  
Class of Warrant or Right [Line Items]  
SCHEDULE OF STOCK WARRANT ACTIVITY

Warrant detail for the year ended June 30, 2025 is reflected below:

 

   Number of Warrants   Weighted Average Exercise Price Per Warrant   Weighted Average Remaining Contract Term (# years) 
Outstanding and exercisable at June 30, 2024   1,413,110   $6.14      
Issued   -    -      
Exercised   -    -      
Forfeited and cancelled             
Outstanding and exercisable at June 30, 2025   1,413,110    6.14    1.48 

 

 

Warrant detail for the year ended June 30, 2024 is reflected below:

 

   Number of Warrants   Weighted Average Exercise Price Per Warrant   Weighted Average Remaining Contract Term (# years) 
Outstanding and exercisable at June 30, 2023   1,455,119   $6.10      
Issued   41,196    3.24      
Exercised   -    -      
Forfeited and cancelled   (83,205)   4.00      
Outstanding and exercisable at June 30, 2024   1,413,110    6.14    2.48 
SCHEDULE OF FAIR VALUE ASSUMPTIONS OF STOCK OPTIONS

The Company uses the Black-Scholes valuation model to calculate the fair value of warrants. The fair value of warrants was measured at the issuance date using the assumptions in the table below:

 

   Year ended June 30, 
    2025(1)   2024 
Expected volatility   -    83.70%
Risk free interest rate   -    4.65%
Dividend yield   -    -%
Expected term (years)        5.00 

 

(1)No warrants were issued during the year ended June 30, 2025.